These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 21440863)
1. Response to inhaled nitric oxide predicts survival in patients with pulmonary hypertension. Krasuski RA; Devendra GP; Hart SA; Wang A; Harrison JK; Bashore TM J Card Fail; 2011 Apr; 17(4):265-71. PubMed ID: 21440863 [TBL] [Abstract][Full Text] [Related]
2. Variable response to inhaled nitric oxide in postoperative patients of mitral stenosis with pulmonary hypertension. Razzaq Z; Aslam M; Hussain MM; Naqvi S; Zameer M; Badar A J Ayub Med Coll Abbottabad; 2009; 21(1):98-102. PubMed ID: 20364753 [TBL] [Abstract][Full Text] [Related]
3. Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. Post MC; Janssens S; Van de Werf F; Budts W Eur Heart J; 2004 Sep; 25(18):1651-6. PubMed ID: 15351165 [TBL] [Abstract][Full Text] [Related]
4. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease. Lee JE; Hillier SC; Knoderer CA J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525 [TBL] [Abstract][Full Text] [Related]
5. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. Clark RH; Huckaby JL; Kueser TJ; Walker MW; Southgate WM; Perez JA; Roy BJ; Keszler M; J Perinatol; 2003 Jun; 23(4):300-3. PubMed ID: 12774137 [TBL] [Abstract][Full Text] [Related]
6. [Inhalation therapy with nitric oxide in pulmonary hypertension: Comparison of preterm infants versus newborn infants]. Schmölzer G; Urlesberger B; Reiterer F; Haim M; Kutschera J; Resch B; Müller W Klin Padiatr; 2003; 215(5):257-61. PubMed ID: 14520586 [TBL] [Abstract][Full Text] [Related]
7. Acute pulmonary hypertension in infants and children: cGMP-related drugs. Fraisse A; Wessel DL Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S37-40. PubMed ID: 20216161 [TBL] [Abstract][Full Text] [Related]
8. Carboxyhemoglobin formation secondary to nitric oxide therapy in the setting of interstitial lung disease and pulmonary hypertension. Ruisi P; Ruisi M South Med J; 2011 Jan; 104(1):46-8. PubMed ID: 21079530 [TBL] [Abstract][Full Text] [Related]
9. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144 [TBL] [Abstract][Full Text] [Related]
10. Early postoperative care of patients with pulmonary hypertension associated with congenital cardiac disease. Adatia I; Beghetti M Cardiol Young; 2009 Aug; 19(4):315-9. PubMed ID: 19493364 [No Abstract] [Full Text] [Related]
11. [Vasodilatator testing with nitric oxide (bronchial control treatment system--BCTS) in patients with pulmonary hypertension]. Podolec P; Kaźnica-Wiatr M; Podolec Z; Krochin M; Wilkołek P; Przybyłowski P; Wierzbicki K; Sadowski J; Zmudka K; Tracz W Przegl Lek; 2004; 61(6):737-42. PubMed ID: 15724676 [TBL] [Abstract][Full Text] [Related]
13. Early experience with inhaled nitric oxide for the treatment of infants and children with pulmonary hypertension. Easa D; Murai DT; Oka B; Dressel M; Vanderford P; Pelke S; Balaraman V Hawaii Med J; 1996 Apr; 55(4):67-9. PubMed ID: 8935980 [TBL] [Abstract][Full Text] [Related]
14. Management of pulmonary arterial hypertension in the neonatal unit. Krishnan U Cardiol Rev; 2010; 18(2):73-5. PubMed ID: 20160532 [TBL] [Abstract][Full Text] [Related]